- Home
- NOTE vs IOBT Comparison
NOTE vs IOBT Comparison
Compare NOTE & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- IOBT
- Stock Information
- Founded
- NOTE 2013
- IOBT 2014
- Country
- NOTE United States
- IOBT Denmark
- Employees
- NOTE N/A
- IOBT N/A
- Industry
- NOTE EDP Services
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- NOTE Technology
- IOBT Health Care
- Exchange
- NOTE Nasdaq
- IOBT Nasdaq
- Market Cap
- NOTE 83.1M
- IOBT 91.6M
- IPO Year
- NOTE N/A
- IOBT 2021
- Fundamental
- Price
- NOTE $0.56
- IOBT $2.22
- Analyst Decision
- NOTE Strong Buy
- IOBT Strong Buy
- Analyst Count
- NOTE 6
- IOBT 3
- Target Price
- NOTE $2.63
- IOBT $9.33
- AVG Volume (30 Days)
- NOTE 2.8M
- IOBT 575.9K
- Earning Date
- NOTE 08-07-2025
- IOBT 08-12-2025
- Dividend Yield
- NOTE N/A
- IOBT N/A
- EPS Growth
- NOTE N/A
- IOBT N/A
- EPS
- NOTE N/A
- IOBT N/A
- Revenue
- NOTE $115,665,000.00
- IOBT N/A
- Revenue This Year
- NOTE N/A
- IOBT N/A
- Revenue Next Year
- NOTE $41.14
- IOBT N/A
- P/E Ratio
- NOTE N/A
- IOBT N/A
- Revenue Growth
- NOTE N/A
- IOBT N/A
- 52 Week Low
- NOTE $0.48
- IOBT $0.66
- 52 Week High
- NOTE $2.03
- IOBT $2.48
- Technical
- Relative Strength Index (RSI)
- NOTE 40.46
- IOBT 66.72
- Support Level
- NOTE $0.54
- IOBT $2.06
- Resistance Level
- NOTE $0.83
- IOBT $2.48
- Average True Range (ATR)
- NOTE 0.08
- IOBT 0.23
- MACD
- NOTE -0.02
- IOBT 0.02
- Stochastic Oscillator
- NOTE 10.03
- IOBT 68.92
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.